SOUTH SAN FRANCISCO, Calif., & AIRPORT CITY, Israel--(BUSINESS WIRE)--Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Eisenberg Brothers Ltd. as its distributor in Israel. Eisenberg Brothers will offer Fluidigm’s complete portfolio of BioMark™, EP1™, and Access Array™ Systems and the complete line up of Dynamic Array™, Digital Array™ and Access Array IFCs for real-time PCR, digital PCR, genotyping, gene expression, copy number variation and absolute quantification for sequencing.
Eisenberg Brothers has a 50-year history in providing high end genetic analysis solutions to research organizations and businesses.
“This exciting partnership with Fluidigm will provide the scientific communities in Israel with powerful genomic tools backed by outstanding support,” noted Amos Grundwag, Manager of the Genomics and Bio Informatics lines at Eisenberg Brothers. “We are happy to add Fluidigm to our portfolio of world leading suppliers. We recognize Fluidigm to be a great solution for a wide range of biological challenges that the scientific community is currently handling.”
“Fluidigm is committed to bringing the accuracy and efficiency benefits of integrated fluidic circuit technology to life science researchers in Israel,” said Dominique Remy-Renou, Vice President of European Sales and Support and General Manager of Fluidigm Europe BV. “Eisenberg Brothers has built a reputation of addressing the needs of Israel’s life sciences research community and we look forward to helping bring the tools needed to solve some of today’s most complex genetic questions in biology all the way down to the single cell.”
About Eisenberg Brothers
Eisenberg Brothers Ltd. is a leading supplier of Scientific, Optical, Electro-Optical, and Medical equipment in Israel. Eisenberg Bros. Ltd. has excellent and extensive connections in the scientific, medical and the high-tech markets in Israel for over 50 years. Eisenberg Brothers is headquartered in Airport City, Israel. Visit their website at http://www.eisenbros.co.il/.
Fluidigm (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including chips and reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets three microfluidic systems including eight different commercial chips to leading pharmaceutical and biotechnology companies, academic institutions, diagnostic laboratories and Ag-Bio companies.
For more information, please visit www.fluidigm.com.
“Fluidigm” and the Fluidigm logo are trademarks or registered trademarks of Fluidigm.